Ramelteon
NDC 50436-3980
Product Information
Ramelteon is a ANDA-approved product labeled by Unit Dose Services. This medication is used to treat sleeplessness (insomnia). It is supplied as a yellow product. This product entry covers the primary NDC 50436-3980 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
I3;5
Code Structure Chart
Product Details
What is NDC 50436-3980?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RAMELTEON (UNII: 901AS54I69)
- RAMELTEON (UNII: 901AS54I69) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- STARCH, CORN (UNII: O8232NY3SJ)
- HYDROXYPROPYL CELLULOSE (110000 WAMW) (UNII: 5Y0974F5PW)
- CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
- TALC (UNII: 7SEV7J4R1U)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 577348 - ramelteon 8 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.
Patient Education
Ramelteon
Ramelteon is used to help patients who have sleep-onset insomnia (difficulty falling asleep) fall asleep more quickly. Ramelteon is in a class of medications called melatonin receptor agonists. It works similarly to melatonin, a natural substance in the brain that is needed for sleep.
[Learn More]
* Please review the full disclaimer at the bottom of this page.